Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

Our objective was to clarify the heterogeneity in response to infliximab treatment in rheumatoid arthritis (RA); to this end, a bioassay was designed to explore the contribution of circulating tumour necrosis factor (TNF)-α bioactivity and its possible link to response. The bioassay is based on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Marotte, Hubert, Maslinski, Wlodzimierz, Miossec, Pierre
Format: Artigo
Language:Inglês
Published: BioMed Central 2005
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064892/
https://ncbi.nlm.nih.gov/pubmed/15642135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1465
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items